Trump's 100% Drug Tariffs: What You Need to Know
Trump's 100% tariffs on imported brand-name drugs include tiered exemptions for companies committing to U.S. manufacturing and price reductions.
drug pricing
8 articles tagged "drug pricing"
Pharma Delays European Drug Launches Over US Pricing Policy
Drug manufacturers are delaying European launches as most-favored-nation pricing threatens to compress US revenues, reshaping global launch strategies in 2026.
Trump Pushes Drug Pricing Legislation in 2026
The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy.
Novo Nordisk Faces Investor Pressure at 2026 Annual Meeting
Novo Nordisk faces shareholder scrutiny as its stock drops 45% since CEO ouster, while rival Eli Lilly surges to a $1 trillion market cap.
Trump Drug Pricing Flaw & Gilead Deal: What to Know
A structural gap in Trump's most-favored nation drug pricing framework raises doubts, while Gilead Sciences makes a major autoimmune therapeutics acquisition.
By Robert Kim
Medicare Chief: TrumpRx Is Narrow in Scope, Not a Full Fix
Medicare chief Chris Klomp says TrumpRx is a limited cash-pay tool, not a sweeping drug pricing overhaul, tempering Trump's transformative claims.
Trump Drug Pricing & GSK Asthma Inhaler Controversy 2026
The White House pushes most-favored-nation drug pricing legislation while a Senate report scrutinizes GSK's asthma inhaler discontinuation strategy.
Trump Drug Prices: Public Opinion vs. Biotech Pushback
A KFF poll reveals partisan divides on Trump drug pricing confidence, while biotech firms publicly challenge the most-favored nation pricing proposal.
By James Liu